Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALBIO.PA Stock Summary
Top 10 Correlated ETFs
ALBIO.PA
In the News
ALBIO.PA Financial details
Company Rating
Strong Buy
Market Cap
90.74M
Income
1M
Revenue
33.48M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
380
Optionable
No
Shortable
Yes
Earnings
19 Jan 2023
P/E
4.27
Forward P/E
18.06
PEG
-0.43
P/S
0.46
P/B
0.56
P/C
-
P/FCF
-3.61
Quick Ratio
2.56
Current Ratio
4.68
Debt / Equity
0.32
LT Debt / Equity
0.31
-
-
EPS (TTM)
0.11
EPS next Y
0.49
EPS next Q
-
EPS this Y
-79.46%
EPS next Y
343.22%
EPS next 5Y
343.22%
EPS last 5Y
103.44%
Revenue last 5Y
44.49%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
12.58%
SMA50
-12.02%
SMA100
-31.35%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
13%
ROC
0.17%
Gross Margin
52%
Oper. Margin
20%
Profit Margin
11%
Payout
-
Shs Outstand
10.25M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
6.78-19.85
52W High
-53.42%
52W Low
+47.5%
RSI
43.15
Rel Volume
0.61
Avg Volume
13.51K
Volume
8.28K
Perf Week
-5.85%
Perf Month
27.71%
Perf Quarter
-31.66%
Perf Half Y
-35.68%
-
-
-
-
Beta
-2.11876
-
-
Volatility
0.19%, 0.72%
Prev Close
-0.67%
Price
8.85
Change
-3.07%
ALBIO.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 3.42 | 3.75 | 17.27 | 37.07 | 19.21 | |
Net income per share | -0.01 | 0.12 | 3.52 | 10.08 | 2.07 | |
Operating cash flow per share | 0 | 0 | 3.55 | 10.65 | 0.48 | |
Free cash flow per share | 0 | 0 | 2.53 | 8.8 | -2.46 | |
Cash per share | 0.22 | 0.27 | 3.49 | 12.8 | 8.52 | |
Book value per share | 3.2 | 3.33 | 6.66 | 16.26 | 15.88 | |
Tangible book value per share | 0.5 | 0.11 | 3.32 | 11.21 | 8.33 | |
Share holders equity per share | 3.2 | 3.33 | 6.66 | 16.26 | 15.88 | |
Interest debt per share | 0.59 | 1.11 | 1.79 | 3.46 | 5.14 | |
Market cap | 22.84M | 23.75M | 147.94M | 271.57M | 141.22M | |
Enterprise value | 26.17M | 31.87M | 132.6M | 174.85M | 106.13M | |
P/E ratio | -421.15 | 21.29 | 4.72 | 2.61 | 6.65 | |
Price to sales ratio | 0.73 | 0.69 | 0.96 | 0.71 | 0.72 | |
POCF ratio | 0 | 0 | 4.68 | 2.47 | 28.56 | |
PFCF ratio | 0 | 0 | 6.57 | 2.99 | -5.62 | |
P/B Ratio | 0.78 | 0.78 | 2.49 | 1.62 | 0.87 | |
PTB ratio | 0.78 | 0.78 | 2.49 | 1.62 | 0.87 | |
EV to sales | 0.84 | 0.93 | 0.86 | 0.46 | 0.54 | |
Enterprise value over EBITDA | 63.9 | 17.18 | 2.51 | 1.18 | 1.68 | |
EV to operating cash flow | 0 | 0 | 4.19 | 1.59 | 21.46 | |
EV to free cash flow | 0 | 0 | 5.89 | 1.93 | -4.22 | |
Earnings yield | 0 | 0.05 | 0.21 | 0.38 | 0.15 | |
Free cash flow yield | 0 | 0 | 0.15 | 0.33 | -0.18 | |
Debt to equity | 0.18 | 0.33 | 0.27 | 0.21 | 0.32 | |
Debt to assets | 0.13 | 0.21 | 0.14 | 0.13 | 0.2 | |
Net debt to EBITDA | 8.14 | 4.38 | -0.29 | -0.65 | -0.55 | |
Current ratio | 3.68 | 3.31 | 2.6 | 3.25 | 4.68 | |
Interest coverage | -0.34 | 8.05 | 203.88 | 405.67 | 77.57 | |
Income quality | 0 | 0 | 1.01 | 1.03 | 0.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.26 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.63 | 0.62 | 0.27 | 0.19 | 0.31 | |
Capex to operating cash flow | 0 | 0 | -0.29 | -0.17 | -6.08 | |
Capex to revenue | 0 | 0 | -0.06 | -0.05 | -0.15 | |
Capex to depreciation | 0 | 0 | -1.26 | -9.33 | -1.12 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.65 | 3.02 | 22.96 | 60.73 | 27.23 | |
ROIC | 0 | 0.04 | 0.98 | -5.04 | 0.39 | |
Return on tangible assets | 0 | 0.06 | 0.39 | 0.48 | 0.12 | |
Graham Net | -0.56 | -1.17 | -1.2 | 4.5 | 1.23 | |
Working capital | 9.04M | 10.54M | 43.7M | 137.64M | 125.52M | |
Tangible asset value | 4.57M | 989.3K | 29.6M | 115.67M | 85.24M | |
Net current asset value | 2.21M | -1.86M | 19.61M | 97.64M | 66.16M | |
Invested capital | 0.18 | 0.33 | 0.27 | 0.21 | 0.32 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.88M | 3.4M | 9.21M | 20.32M | 21.01M | |
Average inventory | 6.37M | 6.95M | 13.36M | 25.11M | 34.41M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 68.08 | 98.85 | 62.28 | 54.3 | 61.23 | |
Days of inventory on hand | 151.65 | 189.78 | 82.25 | 64.56 | 145.88 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 5.36 | 3.69 | 5.86 | 6.72 | 5.96 | |
Inventory turnover | 2.41 | 1.92 | 4.44 | 5.65 | 2.5 | |
ROE | 0 | 0.04 | 0.53 | 0.62 | 0.13 | |
Capex per share | 0 | 0 | -1.02 | -1.84 | -2.94 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -15.34M | -12.07M | -96.72M | -44.07M | -35.09M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.27 | 0.63 | 0.21 | 0.28 | 0.32 | |
Debt to assets | 0.14 | 0.33 | 0.13 | 0.2 | 0.2 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 2.6 | 2.05 | 3.25 | 5.63 | 4.68 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.27 | 0.18 | 0.19 | 0.28 | 0.31 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 43.7M | 101.64M | 137.64M | 132.48M | 125.52M | |
Tangible asset value | 29.6M | 88.82M | 115.67M | 106.48M | 85.24M | |
Net current asset value | 19.61M | 77.13M | 97.64M | 87.48M | 66.16M | |
Invested capital | 0.27 | 0.63 | 0.21 | 0.28 | 0.32 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ALBIO.PA Frequently Asked Questions
What is Biosynex SA stock symbol ?
Biosynex SA is a FR stock and trading under the symbol ALBIO.PA
What is Biosynex SA stock quote today ?
Biosynex SA stock price is $8.85 today.
Is Biosynex SA stock public?
Yes, Biosynex SA is a publicly traded company.